Kausik Ray MD FMedSci/LinkedIn
Nov 1, 2025, 05:15
Kausik Ray Celebrates MENA Launch of ACLY Inhibitor
Kausik Ray, Professor of Public Health at Imperial College London, Past President of European Atherosclerosis Society, posted on LinkedIn:
”One of the exciting things I have had the honoring of doing over the years are launch meetings. Bringing new therapies from the first PCSK9 MAbs, then to the first siRNA inclisiran and now the first ACLY inhibitor Bempedoic acid in the MENA region.
Good discussions about the CVD, lipids, guidelines and where new therapies sit in this this region at high risk for CVD.
The last 15 years of time spent on education, awareness, simplicity continue to help bring improvements in patient care.”
Stay informed with Hemostasis Today.
-
Apr 6, 2026, 07:14Oliver Tiebel: Antiphospholipid Syndrome in Pregnancy – One of Hematology’s Most Complex Challenges
-
Apr 6, 2026, 06:25Katherine Bridge: My First Time at The EHA ReCon
-
Apr 6, 2026, 06:11Priya Prasad: Family Donations Are Not as Safe as We Usually Think
-
Apr 6, 2026, 05:48Isaac Okello: Turning Point from Reliance on Foreign Exports to Self – Reliance Through Local Production of Medical Supplies
-
Apr 6, 2026, 05:34Lena Volland: Scientific Exchange in Bleeding Disorders at the WFH 2026 World Congress
-
Apr 6, 2026, 04:46Ursula Porage Dona: Bringing the Bleeding Disorders Community Together at WFH 2026 with NNHF
-
Apr 6, 2026, 04:17Arun V J: How War Reshaped Blood Transfusion
-
Apr 6, 2026, 03:57Isabella Cieri: How TEG Is Transforming Vascular Surgery Care
-
Apr 5, 2026, 19:00Kausik Ray: Comparing Lipid Management in France vs. Rest of Europe for High Cardiovascular Risk Patients